Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma
Julia Scarisbrick, M. Bagot, Pablo L. Ortiz‐Romero
British Journal of Haematology (2020) Vol. 192, Iss. 4, pp. 683-696
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 180-193
Open Access | Times Cited: 31
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P. Nicolay, Susanne Melchers, J. Albrecht, et al.
Blood (2023) Vol. 142, Iss. 9, pp. 794-805
Open Access | Times Cited: 21
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature
Rosanne Ottevanger, Sylvia van Beugen, Andrea W.M. Evers, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 12, pp. 2377-2387
Open Access | Times Cited: 39
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma
N S B Thomas, Benjamin Christopher, Leticia Reyes, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 76-76
Open Access
Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
A. E. C. Schirren, John D. Albrecht, Susanne Melchers, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 954-966
Open Access | Times Cited: 4
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States
Stefan K. Barta, Nicholas Liu, Maral DerSarkissian, et al.
Clinical Lymphoma Myeloma & Leukemia (2023) Vol. 24, Iss. 2, pp. e21-e32.e4
Open Access | Times Cited: 7
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
Nadia Ninosu, Susanne Melchers, Max Kappenstein, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 141-141
Open Access | Times Cited: 7
Downregulation of miR‐26 promotes invasion and metastasis via targeting interleukin‐22 in cutaneous T‐cell lymphoma
Yuka Matsuda, Sho Ikeda, Fumito Abe, et al.
Cancer Science (2022) Vol. 113, Iss. 4, pp. 1208-1219
Open Access | Times Cited: 11
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial
Pablo L. Ortiz‐Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
The Lancet Haematology (2022) Vol. 9, Iss. 6, pp. e425-e433
Closed Access | Times Cited: 11
Total Skin Treatment with Helical Arc Radiotherapy
Hsin‐Hua Nien, Chen-Hsi Hsieh, Pei‐Wei Shueng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4492-4492
Open Access | Times Cited: 6
Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition
Julia Liang, Eleni Pitsillou, Katherine Ververis, et al.
Chemical Physics Letters (2021) Vol. 788, pp. 139294-139294
Open Access | Times Cited: 13
Mechanism of action of chlormethine gel in mycosis fungoides
Emmanuella Guenova, Pablo L. Ortiz‐Romero, Brian Poligone, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 9, pp. 1739-1748
Open Access | Times Cited: 5
Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
Rosanne Ottevanger, Sylvia van Beugen, Juliette M. Kersten, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 937-937
Open Access | Times Cited: 1
Comparison of the effect of multidrug and single-drug adjuvant chemotherapy on the 5-year survival outcome of high-risk stage II colon cancer
Dandan Song, Minyuan Chen, Ziqi Meng, et al.
Indian Journal of Cancer (2024) Vol. 61, Iss. 3, pp. 662-668
Closed Access | Times Cited: 1
Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study
Cosimo Di Raimondo, Sara Vaccarini, Andrea Nunzi, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 6
Closed Access | Times Cited: 6
Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma
Erin Boh, Drew Kuraitis, Abby Jacobson, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 3, pp. 835-842
Open Access | Times Cited: 3
Cutaneous lymphomas—fast facts about an orphan disease—a short review
Stefanie Porkert, Julia Valencak
memo - Magazine of European Medical Oncology (2023) Vol. 16, Iss. 1, pp. 10-16
Open Access | Times Cited: 2
Cutaneous T‐cell lymphoma—Focus on some problems, and some solutions
Helmut Beltraminelli
Hematological Oncology (2023) Vol. 41, Iss. S1, pp. 20-24
Open Access | Times Cited: 2
Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
Lina U. Ivert, Anna H. Winther, Pontus Jonsson, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The notch sign as a clue for the diagnosis of early cutaneous T-cell lymphoma
Evelyne Harkemanne, Léo‐Paul Secco, Marie Baeck
JAAD Case Reports (2024) Vol. 56, pp. 20-22
Closed Access
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Francine M. Foss, Youn H. Kim, H. Miles Prince, et al.
Journal of Clinical Oncology (2024)
Closed Access
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
Georgia Biazus Soares, Joan Guitart, Gil Yosipovitch
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 67-77
Closed Access | Times Cited: 1
Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T‐cell lymphoma
Daniel Aires, Sunil Abhyankar
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 809-816
Closed Access | Times Cited: 1
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma
J Salant, Niloufer Khan, Judith E. Nelson, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 6, pp. 958-963
Open Access | Times Cited: 1
“Knock Me Out”: The Challenges of Managing Pain Due to Cutaneous T Cell Lymphomas: A Case Report
Shila Pandey, Andrea Dolan, Moe Norton-Westbrook, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 11, pp. 1740-1746
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top